Montag & Associates’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.48K Sell
70
-271
-79% -$17.8K ﹤0.01% 817
2026
Q1
$24.3K Hold
341
﹤0.01% 662
2025
Q4
$28K Buy
341
+175
+105% +$13.6K ﹤0.01% 666
2025
Q3
$12.5K Hold
166
﹤0.01% 737
2025
Q2
$12.3K Sell
166
-1,140
-87% -$79.4K ﹤0.01% 726
2025
Q1
$105K Hold
1,306
0.01% 496
2024
Q4
$102K Hold
1,306
﹤0.01% 496
2024
Q3
$123K Sell
1,306
-167
-11% -$14K 0.01% 480
2024
Q2
$115K Hold
1,473
0.01% 476
2024
Q1
$134K Hold
1,473
0.01% 456
2023
Q4
$114K Hold
1,473
0.01% 458
2023
Q3
$100K Hold
1,473
0.01% 457
2023
Q2
$120K Hold
1,473
0.01% 452
2023
Q1
$121K Buy
+1,473
New +$105K 0.01% 444

Other funds holding GEHC

Montag & Associates's GEHC Position: Q2 2026 in Review

Montag & Associates reduced its GE HealthCare (GEHC) stake by 79% in Q2 2026, selling an estimated $17.8K and leaving 70 shares worth $4.48K. The position accounts for ﹤0.01% of the portfolio, ranked #817.

Montag & Associates first reported a position in GEHC in Q1 2023 and has held it in 14 quarters since. The position peaked at $134K in Q1 2024. 1,223 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Montag & Associates held 70 shares of GE HealthCare worth $4.48K as of Q2 2026.
  • Montag & Associates sold 271 GE HealthCare shares in Q2 2026, an estimated $17.8K.
  • GE HealthCare made up ﹤0.01% of Montag & Associates's portfolio in Q2 2026, its #817 holding.
  • Montag & Associates first reported a position in GE HealthCare in Q1 2023 and has held it in 14 quarters since.
  • Montag & Associates's GE HealthCare position peaked at $134K in Q1 2024.
  • 1,223 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Montag & Associates's 13F filing for Q2 2026, filed 5 Aug 2026.